SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 524.29 |
| Enterprise Value ($M) | 534.25 |
| Book Value ($M) | 147.85 |
| Book Value / Share | 0.70 |
| Price / Book | 3.55 |
| NCAV ($M) | 135.98 |
| NCAV / Share | 0.65 |
| Price / NCAV | 3.86 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.58 |
| Return on Assets (ROA) | -0.65 |
| Return on Equity (ROE) | -0.84 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 14.91 |
| Current Ratio | 14.91 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 177.44 |
| Assets | 189.32 |
| Liabilities | 41.47 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -103.20 |
| Net Income | -95.88 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -89.09 |
| Cash from Investing | -39.94 |
| Cash from Financing | 117.58 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Frazier Life Sciences Public Fund, L.P. | 6.60 | 32.35 | |
| 13D/A | Bain Capital Life Sciences Fund II, L.P. | 9.99 | 20.84 | |
| 13G | Vestal Point Capital, LP | 6.30 | ||
| 13G/A | Farallon Capital Partners, L.P. | 9.99 | 2.96 | |
| 13G/A | Wellington Management Group Llp | 3.20 | -36.44 | |
| 13G/A | Prudential Financial Inc | 4.50 | -24.29 | |
| 13G/A | Adage Capital Management, L.P. | 4.10 | ||
| 13G/A | Jennison Associates Llc | 4.10 | -23.62 | |
| 13G | BlackRock, Inc. | 5.70 | 0.00 | |
| 13D/A | Growth Equity Opportunities 17, LLC | 14.90 | 0.00 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 259,664 | 839,225 | 30.94 | |
| 364,352 | 941,805 | 38.69 | |
| 392,937 | 2,287,019 | 17.18 | |
| 384,893 | 1,556,683 | 24.73 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| SRRK – Scholar Rock Holding Corporation | STOK – Stoke Therapeutics, Inc. |
| STTK – Shattuck Labs, Inc. | SWTX – SpringWorks Therapeutics, Inc. |
| SYRE – Spyre Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io